Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Beschreibung

Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers. It has been used to help those with autism, chronic fatigue, and depression find relief, and latest research points to its potential for long covid, mold toxicity, even longevity. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? Find out more about the potential of LDN from leading international medical professionals in this updated, third book, edited by Linda Elsegood, founder of The LDN Trust.

Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers. It has been used to help those with autism, chronic fatigue, and depression find relief, and latest research points to its potential for long covid, mold toxicity, even longevity. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? Find out more about the potential of LDN from leading international medical professionals in this updated, third book, edited by Linda Elsegood, founder of The LDN Trust.

Details
Erscheinungsjahr: 2022
Fachbereich: Homöopathie
Genre: Importe, Medizin
Rubrik: Wissenschaften
Medium: Taschenbuch
Inhalt: Kartoniert / Broschiert
ISBN-13: 9781739107000
ISBN-10: 1739107004
Sprache: Englisch
Einband: Kartoniert / Broschiert
Redaktion: Elsegood, Linda
Hersteller: LDN Research Trust
Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße: 228 x 153 x 24 mm
Von/Mit: Linda Elsegood
Erscheinungsdatum: 10.11.2022
Gewicht: 0,674 kg
Artikel-ID: 126673168